Menu
GeneBe

X-47565130-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001654.5(ARAF):c.449A>G(p.Asn150Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000386 in 1,192,238 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000091 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000042 ( 0 hom. 19 hem. )

Consequence

ARAF
NM_001654.5 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.832
Variant links:
Genes affected
ARAF (HGNC:646): (A-Raf proto-oncogene, serine/threonine kinase) Enables protein serine/threonine kinase activity. Involved in negative regulation of apoptotic process; regulation of TOR signaling; and regulation of cellular protein metabolic process. Predicted to be active in cytosol and mitochondrion. Biomarker of high grade glioma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03443244).
BS2
High Hemizygotes in GnomAdExome at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ARAFNM_001654.5 linkuse as main transcriptc.449A>G p.Asn150Ser missense_variant 5/16 ENST00000377045.9
ARAFNM_001256196.2 linkuse as main transcriptc.449A>G p.Asn150Ser missense_variant 5/16
ARAFNM_001256197.2 linkuse as main transcriptc.449A>G p.Asn150Ser missense_variant 5/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ARAFENST00000377045.9 linkuse as main transcriptc.449A>G p.Asn150Ser missense_variant 5/161 NM_001654.5 P1P10398-1
ARAFENST00000377039.2 linkuse as main transcriptc.449A>G p.Asn150Ser missense_variant 5/62 P10398-2
ARAFENST00000489496.1 linkuse as main transcriptn.369A>G non_coding_transcript_exon_variant 4/45

Frequencies

GnomAD3 genomes
AF:
0.00000905
AC:
1
AN:
110480
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33110
show subpopulations
Gnomad AFR
AF:
0.0000329
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000997
AC:
18
AN:
180545
Hom.:
0
AF XY:
0.0000917
AC XY:
6
AN XY:
65415
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000588
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000531
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000125
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000416
AC:
45
AN:
1081758
Hom.:
0
Cov.:
32
AF XY:
0.0000540
AC XY:
19
AN XY:
352060
show subpopulations
Gnomad4 AFR exome
AF:
0.000461
Gnomad4 AMR exome
AF:
0.000486
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000186
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000965
Gnomad4 OTH exome
AF:
0.000110
GnomAD4 genome
AF:
0.00000905
AC:
1
AN:
110480
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33110
show subpopulations
Gnomad4 AFR
AF:
0.0000329
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000718
ExAC
AF:
0.0000824
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2022The c.449A>G (p.N150S) alteration is located in exon 5 (coding exon 4) of the ARAF gene. This alteration results from a A to G substitution at nucleotide position 449, causing the asparagine (N) at amino acid position 150 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.56
Cadd
Benign
7.8
Dann
Benign
0.59
DEOGEN2
Benign
0.24
T;T;.
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.43
T;T;T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.034
T;T;T
MetaSVM
Benign
-0.64
T
MutationTaster
Benign
0.92
N;N;N
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.42
N;N;N
REVEL
Benign
0.17
Sift
Benign
0.76
T;T;T
Sift4G
Benign
0.81
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.13
MutPred
0.38
Gain of disorder (P = 0.0349);Gain of disorder (P = 0.0349);Gain of disorder (P = 0.0349);
MVP
0.51
MPC
0.061
ClinPred
0.015
T
GERP RS
0.79
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.020
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs774526444; hg19: chrX-47424529; COSMIC: COSV105865980; COSMIC: COSV105865980; API